# Myocardial Perfusion MRI

> **NCT01490294** · PHASE2 · COMPLETED · sponsor: **Bayer** · enrollment: 232 (actual)

## Conditions studied

- Myocardial Perfusion Imaging
- Magnetic Resonance Imaging

## Interventions

- **DRUG:** Gadobutrol (Gadavist,Gadovist, BAY86-4875)
- **DRUG:** Gadobutrol (Gadavist,Gadovist, BAY86-4875)
- **DRUG:** Gadobutrol (Gadavist,Gadovist, BAY86-4875)
- **DRUG:** Gadobutrol (Gadavist,Gadovist, BAY86-4875)

## Key facts

- **NCT ID:** NCT01490294
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-03
- **Primary completion:** 2006-05
- **Final completion:** 2006-05
- **Target enrollment:** 232 (ACTUAL)
- **Last updated:** 2014-05-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01490294

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01490294, "Myocardial Perfusion MRI". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT01490294. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*